FDA panel recommends revoking the approval of controversial drug for preterm births
Makena, the only drug approved to prevent premature births, has not shown to be effective and exposes women to “serious risk," the agency's scientists...
FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs
Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able...
Covid infection changes genetic material of cells: Study
Washington: Scientists have shown for the first time that infection by SARS-CoV-2 changes the functioning of host cell RNA, according to a study.The scientists...
Rejuvenated immune cells can improve clearance of toxic waste from brain
Alzheimer's, Parkinson's and many other neurodegenerative diseases are marked by damaging clusters of proteins in the brain. Scientists have expended enormous effort searching for...
Developing therapies for treatment-resistant prostate cancer
Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical...
